Picture of Hanmi Pharm logo

128940 — Hanmi Pharm News Story

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapHigh Flyer

Brief: Hanmi Pharmaceutical: Janssen Pharmaceuticals Decides To Return Rights For Obesity/Diabetes Drug To Hanmi

July 3 (Reuters) - Hanmi Pharm Co Ltd  128940.KS  Says:
    * JANSSEN PHARMACEUTICALS DECIDES TO RETURN RIGHTS FOR
OBESITY/DIABETES DRUG, HM12525A, TO HANMI
    * IT WILL NOT RETURN AN UPFRONT PAYMENT OF $105 MILLION TO
JANSSEN
PHARMACEUTICALS

Source text for Eikon in Korean: https://bit.ly/2LzJ6HY
Further company coverage:  128940.KS 

 ((Heekyong.Yang@thomsonreuters.com;))

Recent news on Hanmi Pharm

See all news